Fast Five Quiz: Eosinophilic Asthma

Zab Mosenifar, MD


March 17, 2023

Unlike patients with EA, those with NEA have either high levels of other inflammatory cell types, such as neutrophils, or no dominant inflammatory cells in the airway, blood, or sputum. NEA has not been researched as much as EA, resulting in few targeted therapies for this subtype. Nonpharmacologic interventions, "off-label" use of licensed drugs, novel small molecules, and biologics agents are being investigated as possible treatments for NEA.

Learn more about the difference between EA and NEA.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.